PAH News

August 12, 2020August 12, 2020

Liquida’s LIQ861 Found to Improve Exercise Capacity, Quality of Life in PAH

News, PAH News

LIQ861, Liquidia Technologies’ proprietary inhaled dry powder formulation of the vasodilator treprostinil, improves exercise capacity and quality of life for people with pulmonary arterial hypertension (PAH), according to data ... Read more

August 10, 2020August 10, 2020

5-year Survival Rate Lower in Congenital Heart Disease Patients With PAH

News, PAH News

The five-year survival rate is markedly reduced among adults with pulmonary arterial hypertension (PAH) due to congenital heart disease (CHD), compared with other types of CHD, real-world data from ... Read more

August 7, 2020August 7, 2020

Aerovate Raises $72.6M to Develop Potential PAH Inhaled Therapy AV-101

News, PAH News

Aerovate Therapeutics received $72.6 million in Series A funding to advance trials testing AV-101, an experimental inhaled version of imatinib for the treatment of pulmonary arterial hypertension (PAH). AV-101 is ... Read more

July 29, 2020July 29, 2020

PAH Caused by Undiagnosed Systemic Sclerosis in Case Study

News, PAH News

A case report found a patient’s pulmonary arterial hypertension (PAH) was caused by an undiagnosed case of the autoimmune disorder systemic sclerosis (SSc), highlighting the need for early and thorough ... Read more

July 27, 2020July 27, 2020

Outcomes Better for PAH Patients Treated at Specialty Centers, Study Finds

News, PAH News

People with pulmonary arterial hypertension (PAH) who are treated at specialty care centers have better survival chances and a lower likelihood of hospitalization, a study reports. These findings support ... Read more

July 22, 2020July 30, 2020

Opsumit Can Lower Mortality Risk in PAH Patients, Study Contends

News, PAH News

When used alone or in combination with other therapies, Opsumit (macitentan) can lower the mortality risk in patients with pulmonary arterial hypertension (PAH), a study found. The study, “Changes ... Read more

July 20, 2020July 20, 2020

Specialist Care Needed Throughout High-risk Pregnancies of PAH Patients, Study Says

News, PAH News

Pregnant women with pulmonary arterial hypertension (PAH) should seek specialist care before giving birth and for months afterward, due to the risk of severe maternal complications and high rates ... Read more

July 17, 2020July 17, 2020

Interleukin-32 Shows Potential as Early Biomarker for PAH in Scleroderma Patients

News, PAH News

A protein called interleukin-32 may serve as a biomarker for pulmonary arterial hypertension (PAH) in scleroderma patients, for whom PAH is a severe complication. The study reporting the findings, “Interleukin-32 ... Read more

July 15, 2020July 15, 2020

Liquidia to Expand PAH Treatment Efforts With RareGen Acquisition

News, PAH News

Liquidia Technologies, a company developing an inhaled form of treprostinil for pulmonary arterial hypertension (PAH), has established an agreement to acquire the rare disease company and marketer of generic treprostinil ... Read more

June 29, 2020July 17, 2020

Sotatercept Reduces Heart Strain, Improves Functional Capacity in PAH, Data Show

News, PAH News

Sotatercept (ACE-011) leads to clinically meaningful reductions in heart strain and improvements in functional capacity in patients with pulmonary arterial hypertension (PAH), top-line data from a Phase 2 trial ... Read more

Pin It on Pinterest